Literature DB >> 34410886

Novel Artificial Intelligence-based Technology for Chest Computed Tomography Analysis of Idiopathic Pulmonary Fibrosis.

Tomohiro Handa1,2, Kiminobu Tanizawa1, Tsuyoshi Oguma1, Ryuji Uozumi3, Kizuku Watanabe1, Naoya Tanabe1, Takafumi Niwamoto1, Hiroshi Shima1, Ryobu Mori1, Tomomi W Nobashi4, Ryo Sakamoto4, Takeshi Kubo4, Atsuko Kurosaki5, Kazuma Kishi6, Yuji Nakamoto4, Toyohiro Hirai1.   

Abstract

Rationale: There is a growing need to accurately estimate the prognosis of idiopathic pulmonary fibrosis (IPF) in clinical practice, given the development of effective drugs for treating IPF.
Objectives: To develop artificial intelligence-based image analysis software to detect parenchymal and airway abnormalities on computed tomographic (CT) imaging of the chest and to explore their prognostic importance in patients with IPF.
Methods: A novel artificial intelligence-based quantitative CT image analysis software (AIQCT) was developed by applying 304 high-resolution CT (HRCT) scans from patients with diffuse lung diseases as the training set. AIQCT automatically categorized and quantified 10 types of parenchymal patterns as well as airways, expressing the volumes as percentages of the total lung volume. To validate the software, the area percentages of each lesion quantified by AIQCT were compared with those of the visual scores using 30 plain high-resolution CT images with lung diseases. In addition, three-dimensional analysis for similarity with ground truth was performed using HRCT images from 10 patients with IPF. AIQCT was then applied to 120 patients with IPF who underwent HRCT scanning of the chest at our institute. Associations between the measured volumes and survival were analyzed.
Results: The correlations between AIQCT and the visual scores were moderate to strong (correlation coefficient 0.44-0.95) depending on the parenchymal pattern. The Dice indices for similarity between AIQCT data and ground truth were 0.67, 0.76, and 0.64 for reticulation, honeycombing, and bronchi, respectively. During a median follow-up period of 2,184 days, 66 patients died, and 1 underwent lung transplantation. In multivariable Cox regression analysis, bronchial volumes (adjusted hazard ratio [HR], 1.33; 95% confidence interval [CI], 1.16-1.53) and normal lung volumes (adjusted HR, 0.97; 95% CI, 0.94-0.99) were independently associated with survival after adjusting for the gender-age-lung physiology stage of IPF. Conclusions: Our newly developed artificial intelligence-based image analysis software successfully quantified parenchymal lesions and airway volumes. Bronchial and normal lung volumes on HRCT imaging of the chest may provide additional prognostic information on the gender-age-lung physiology stage of IPF.

Entities:  

Keywords:  airway; deep learning; interstitial lung disease; prognosis; traction bronchiectasis

Mesh:

Year:  2022        PMID: 34410886     DOI: 10.1513/AnnalsATS.202101-044OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  4 in total

1.  Quantitative analysis of high-resolution computed tomography features of idiopathic pulmonary fibrosis: a structure-function correlation study.

Authors:  Haishuang Sun; Min Liu; Han Kang; Xiaoyan Yang; Peiyao Zhang; Rongguo Zhang; Huaping Dai; Chen Wang
Journal:  Quant Imaging Med Surg       Date:  2022-07

2.  Idiopathic Pulmonary Fibrosis Mortality Risk Prediction Based on Artificial Intelligence: The CTPF Model.

Authors:  Xuening Wu; Chengsheng Yin; Xianqiu Chen; Yuan Zhang; Yiliang Su; Jingyun Shi; Dong Weng; Xing Jiang; Aihong Zhang; Wenqiang Zhang; Huiping Li
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

3.  An Entropy-Based Measure of Complexity: An Application in Lung-Damage.

Authors:  Pilar Ortiz-Vilchis; Aldo Ramirez-Arellano
Journal:  Entropy (Basel)       Date:  2022-08-14       Impact factor: 2.738

4.  Kernel Conversion for Robust Quantitative Measurements of Archived Chest Computed Tomography Using Deep Learning-Based Image-to-Image Translation.

Authors:  Naoya Tanabe; Shizuo Kaji; Hiroshi Shima; Yusuke Shiraishi; Tomoki Maetani; Tsuyoshi Oguma; Susumu Sato; Toyohiro Hirai
Journal:  Front Artif Intell       Date:  2022-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.